Last reviewed · How we verify
NCT06980129: RITH4Hips
Rehabilitation in the Home After Hip Fracture
NA trial testing Rehabilitation in the home in Hip Fractures (ICD-10 72.01-72.2) in 220 participants. Not yet recruiting.
31 July 2027
Quick facts
| Lead sponsor | South West Sydney Local Health District |
|---|---|
| Phase | NA |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | health services research |
| Enrollment | 220 |
| Start date | 1 June 2025 |
| Primary completion | 31 July 2027 |
| Estimated completion | 20 September 2027 |
| Sites | 3 locations across Australia |
Drugs / interventions tested
- Rehabilitation in the home
- Usual care inpatient rehabilitation
Conditions studied
- Hip Fractures (ICD-10 72.01-72.2) — all drugs for Hip Fractures (ICD-10 72.01-72.2) →
- Rehabilitation Program — all drugs for Rehabilitation Program →
Sponsor
South West Sydney Local Health District — full company profile →
Who can join
50 and older, any sex, with Hip Fractures (ICD-10 72.01-72.2) or Rehabilitation Program. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Hip fractures are common, especially in older adults, and they can have a big impact on health and quality of life. In Australia, hip fractures are a significant healthcare challenge. After surgery, patients often need rehabilitation to regain mobility, but this usually involves long hospital stays. The RITH4Hips trial will determine if a program where patients receive rehabilitation at home (instead of in the hospital) is similar to conventional inpatient rehabilitation. Objectives: The main goal of this study is to find out if rehabilitation at home after surgery for a hip fracture works as well as rehabilitation in the hospital. The investigators also want to see if the home rehabilitation program can reduce the time spent in a hospital bed and improve other aspects like quality of life, mobility, and pain management. Methods: This study will involve older adults who have had surgery due to a low-trauma hip fracture. Participants will be randomly assigned to either the usual care inpatient rehabilitation or the Rehabilitation in the Home (RITH) program. The investigators will measure outcomes such as how well patients can move, how much pain they experience, how their quality of life improves, and how much time they spend in the hospital. Expected Outcomes: The investigators expect that the home rehabilitation program will be just similar to inpatient rehabilitation in helping patients recover mobility. The investigators also hope to find that it will reduce the time patients spend in a hospital bed, improve their quality of life, reduce fear of falling, and lessen the burden on carers. Additionally, the investigators aim to show that the home program is more cost-effective than hospital-based rehabilitation.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06980129
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Hip Fractures (ICD-10 72.01-72.2)
Currently open trials in the same condition.
- NCT06678529 — Effect of Transcranial Direct Current Stimulation on Postoperative Delirium in Elderly Patients · NA · recruiting
- NCT07189260 — Pre- and Postoperative Chest Therapy With Positive Expiratory Pressure (PEP) to Prevent Hospital-acquired Pneumonia · NA · recruiting
Other South West Sydney Local Health District trials
Trials by the same sponsor.
- NCT07292519 — Tirzepatide Combined With Cognitive-Behavioural Therapy (CBT) for Adults With Alcohol Use Disorder (AUD) and Overweight/ · Phase 2 · not yet recruiting
- NCT07247370 — Ketamine-Enhanced Therapy for Individuals With Alcohol Use Disorder and Depression: A Pilot Study (KET-DUAL) · Phase 1, PHASE2 · not yet recruiting
- NCT05540834 — Viscoelastic Testing Guided Tissue Plasminogen Activator Treatment in Acute Respiratory Failure · Phase 2 · recruiting
- NCT05082168 — Capnodynamic Monitoring of Cardiorespiratory Function in Critically Ill Patients · unknown
- NCT04303455 — Renin as a Biomarker of Haemodynamic Normalisation · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06980129 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by South West Sydney Local Health District
- Last refreshed: 20 May 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06980129.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing